Dexcom CEO discusses future applications of continuous glucose monitors and provides updates on WiSeR and Epic market share
read at STAT ↗Neutral
Dexcom's chief executive spoke about potential new uses for the company's continuous glucose monitoring technology, suggesting that the device could play a broader role in health management beyond its current diabetes focus.
He also gave brief updates on the company's WiSeR platform and noted Epic's growing market share in the healthcare software space, indicating ongoing competition among health tech providers.
The remarks were shared in STAT's Health Tech newsletter, which is available to subscribers through the STAT+ service.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Dexcom CEO hints at future uses for CGM”
read at STAT ↗466 words · retrieved May 19
comments(0)
5-min edit window · permanent after that